(Total Views: 460)
Posted On: 04/26/2025 4:12:22 PM
Post# of 154725
Creatv Bio, a division of Creatv Microtech, Inc. working in conjunction with Bria Cell Therapeutics.
Bria Cell stock rises on Positive Survival Data from Study in Cancer Patients: Retail gets more bullish.
HR+metastic breast cancer patients treated with Bria-IMT plus check point inhibitors... had a median overal survival (OS) of 17.3 months, exceeding the 14.4 months achieved with Trodelvy... in similar heavily pre-treated patients.
I wonder if Bria will be at the ESMO Conference?
Bria Cell stock rises on Positive Survival Data from Study in Cancer Patients: Retail gets more bullish.
HR+metastic breast cancer patients treated with Bria-IMT plus check point inhibitors... had a median overal survival (OS) of 17.3 months, exceeding the 14.4 months achieved with Trodelvy... in similar heavily pre-treated patients.
I wonder if Bria will be at the ESMO Conference?
(2)
(0)
